The Myelodysplastic Syndromes Channel is supported with funding from Geron (Silver).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
IBC 2024 | CHIP & CCUS: knowledge gaps, ongoing trials & recommendations for hematologists
In this discussion, leading experts Uma Borate, MD, The Ohio State University, Columbus, OH, Eric Padron, MD, Moffitt Cancer Center, Tampa, FL, and Kelly Bolton, MD, PhD, Washington University School of Medicine, St. Louis, MO, give an overview of current knowledge gaps in clonal hematopoiesis, ongoing trials in clonal cytopenia of undetermined significance (CCUS), and share their recommendations for practising hematologists on how to approach individuals with clonal hematopoiesis of indeterminate potential (CHIP) and CCUS. This session was filmed at IBC 2024, held in Lisbon, Portugal.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
